237 related articles for article (PubMed ID: 22798622)
1. Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms.
Ochala J; Gokhin DS; Pénisson-Besnier I; Quijano-Roy S; Monnier N; Lunardi J; Romero NB; Fowler VM
Hum Mol Genet; 2012 Oct; 21(20):4473-85. PubMed ID: 22798622
[TBL] [Abstract][Full Text] [Related]
2. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C
Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096
[TBL] [Abstract][Full Text] [Related]
3. Congenital myopathy-related mutations in tropomyosin disrupt regulatory function through altered actin affinity and tropomodulin binding.
Moraczewska J; Robaszkiewicz K; Śliwinska M; Czajkowska M; Ly T; Kostyukova A; Wen H; Zheng W
FEBS J; 2019 May; 286(10):1877-1893. PubMed ID: 30768849
[TBL] [Abstract][Full Text] [Related]
4. Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patients.
Marston S; Memo M; Messer A; Papadaki M; Nowak K; McNamara E; Ong R; El-Mezgueldi M; Li X; Lehman W
Hum Mol Genet; 2013 Dec; 22(24):4978-87. PubMed ID: 23886664
[TBL] [Abstract][Full Text] [Related]
5. Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy.
Ottenheijm CA; Lawlor MW; Stienen GJ; Granzier H; Beggs AH
Hum Mol Genet; 2011 May; 20(10):2015-25. PubMed ID: 21357678
[TBL] [Abstract][Full Text] [Related]
6. Myopathy-causing Q147P TPM2 mutation shifts tropomyosin strands further towards the open position and increases the proportion of strong-binding cross-bridges during the ATPase cycle.
Karpicheva OE; Simonyan AO; Kuleva NV; Redwood CS; Borovikov YS
Biochim Biophys Acta; 2016 Mar; 1864(3):260-267. PubMed ID: 26708479
[TBL] [Abstract][Full Text] [Related]
7. Troponin and a Myopathy-Linked Mutation in
Robaszkiewicz K; Wróbel J; Moraczewska J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003645
[TBL] [Abstract][Full Text] [Related]
8. Thin filament dysfunctions caused by mutations in tropomyosin Tpm3.12 and Tpm1.1.
Moraczewska J
J Muscle Res Cell Motil; 2020 Mar; 41(1):39-53. PubMed ID: 31270709
[TBL] [Abstract][Full Text] [Related]
9. Functional effects of congenital myopathy-related mutations in gamma-tropomyosin gene.
Robaszkiewicz K; Dudek E; Kasprzak AA; Moraczewska J
Biochim Biophys Acta; 2012 Oct; 1822(10):1562-9. PubMed ID: 22749829
[TBL] [Abstract][Full Text] [Related]
10. A myopathy-linked tropomyosin mutation severely alters thin filament conformational changes during activation.
Ochala J; Iwamoto H; Larsson L; Yagi N
Proc Natl Acad Sci U S A; 2010 May; 107(21):9807-12. PubMed ID: 20457903
[TBL] [Abstract][Full Text] [Related]
11. Mutations Q93H and E97K in
Śliwinska M; Robaszkiewicz K; Wasąg P; Moraczewska J
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919826
[TBL] [Abstract][Full Text] [Related]
12. Congenital myopathies: diseases of the actin cytoskeleton.
Clarkson E; Costa CF; Machesky LM
J Pathol; 2004 Nov; 204(4):407-17. PubMed ID: 15495263
[TBL] [Abstract][Full Text] [Related]
13. Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.
Yuen M; Cooper ST; Marston SB; Nowak KJ; McNamara E; Mokbel N; Ilkovski B; Ravenscroft G; Rendu J; de Winter JM; Klinge L; Beggs AH; North KN; Ottenheijm CA; Clarke NF
Hum Mol Genet; 2015 Nov; 24(22):6278-92. PubMed ID: 26307083
[TBL] [Abstract][Full Text] [Related]
14. The Primary Causes of Muscle Dysfunction Associated with the Point Mutations in Tpm3.12; Conformational Analysis of Mutant Proteins as a Tool for Classification of Myopathies.
Borovikov YS; Karpicheva OE; Simonyan AO; Avrova SV; Rogozovets EA; Sirenko VV; Redwood CS
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544720
[TBL] [Abstract][Full Text] [Related]
15. Tropomyosins in skeletal muscle diseases.
Kee AJ; Hardeman EC
Adv Exp Med Biol; 2008; 644():143-57. PubMed ID: 19209820
[TBL] [Abstract][Full Text] [Related]
16. TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype.
Donkervoort S; Papadaki M; de Winter JM; Neu MB; Kirschner J; Bolduc V; Yang ML; Gibbons MA; Hu Y; Dastgir J; Leach ME; Rutkowski A; Foley AR; Krüger M; Wartchow EP; McNamara E; Ong R; Nowak KJ; Laing NG; Clarke NF; Ottenheijm C; Marston SB; Bönnemann CG
Ann Neurol; 2015 Dec; 78(6):982-994. PubMed ID: 26418456
[TBL] [Abstract][Full Text] [Related]
17. Thin filament proteins mutations associated with skeletal myopathies: defective regulation of muscle contraction.
Ochala J
J Mol Med (Berl); 2008 Nov; 86(11):1197-204. PubMed ID: 18574571
[TBL] [Abstract][Full Text] [Related]
18. Tropomyosin 3 (TPM3) function in skeletal muscle and in myopathy.
Lambert MR; Gussoni E
Skelet Muscle; 2023 Nov; 13(1):18. PubMed ID: 37936227
[TBL] [Abstract][Full Text] [Related]
19. [Congenital myopathies - skeletal muscle diseases related to disorder of actin filament structure and functions].
Robaszkiewicz K; Moraczewska J
Postepy Hig Med Dosw (Online); 2011 Jun; 65():347-56. PubMed ID: 21677359
[TBL] [Abstract][Full Text] [Related]
20. Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy.
Citirak G; Witting N; Duno M; Werlauff U; Petri H; Vissing J
Neuromuscul Disord; 2014 Apr; 24(4):325-30. PubMed ID: 24507666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
